Eton Pharmaceuticals, Inc. ETON Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s change in AR?
- Eton Pharmaceuticals, Inc. (ETON) reported change in AR of $1.65M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s change in AR changed year-over-year?
- Eton Pharmaceuticals, Inc.'s change in AR decreased by 85.0% year-over-year, from $11.04M to $1.65M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s change in AR?
- Over 2 years (2021 to 2024), Eton Pharmaceuticals, Inc.'s change in AR has grown at a -24.2% compound annual growth rate (CAGR), from $5.42M to $3.12M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.